Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FFL9Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $155,850
Award facts
- Contract value 100% obligated
- $155,850.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $155,850.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 30, 2026, for RINVOQ ER 15 mg tablets in quantities of 30s. This non-set-aside competitive award is scheduled for ultimate completion on February 2, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. RINVOQ is a Janus kinase (JAK) inhibitor used to treat rheumatoid arthritis and other inflammatory conditions, representing a specialized pharmaceutical product delivered through the federal medical supply chain to support military healthcare programs.
This delivery order operates as a task order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military treatment facilities and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FFL9Q?
SPE2DR26FFL9Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FFL9Q worth?
The government has obligated $155,850 on SPE2DR26FFL9Q.
Is contract SPE2DR26FFL9Q an order under another contract?
Yes. SPE2DR26FFL9Q is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFL9Q competed?
The extent of competition for SPE2DR26FFL9Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award